{
    "startDate": "2021-01-01",
    "endDate": "2021-06-30",
    "year": "2021",
    "quarter": "Q2",
    "symbol": "LABP",
    "data": {
        "bs": [
            {
                "label": "Total current assets",
                "concept": "AssetsCurrent",
                "unit": "usd",
                "value": 117727000
            },
            {
                "label": "Convertible preferred stock, $0.01 par value, no shares authorized, issued or outstanding as of June 30, 2021; 11,260,608 shares authorized, issued and outstanding as of December 31, 2020: aggregate liquidation preference of $70,254 as of December 31, 2020",
                "concept": "TemporaryEquityValueExcludingAdditionalPaidInCapital",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Deferred offering costs",
                "concept": "DeferredOfferingCosts",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Cash and cash equivalents",
                "concept": "CashAndCashEquivalentsAtCarryingValue",
                "unit": "usd",
                "value": 18687000
            },
            {
                "label": "Marketable securities, available for sale",
                "concept": "MarketableSecuritiesCurrent",
                "unit": "usd",
                "value": 96440000
            },
            {
                "label": "Property, plant and equipment-net",
                "concept": "PropertyPlantAndEquipmentNet",
                "unit": "usd",
                "value": 564000
            },
            {
                "label": "Total liabilities, convertible preferred stock and stockholders' (deficit) equity",
                "concept": "LiabilitiesAndStockholdersEquity",
                "unit": "usd",
                "value": 118291000
            },
            {
                "label": "Preferred stock, $0.01 par value; 10,000,000 shares authorized, no shares issued or outstanding as of June 30, 2021",
                "concept": "PreferredStockValue",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Total assets",
                "concept": "Assets",
                "unit": "usd",
                "value": 118291000
            },
            {
                "label": "Incentive and tax receivables",
                "concept": "labp:IncentiveAndIncomeTaxReceivables",
                "unit": "usd",
                "value": 2000
            },
            {
                "label": "Accumulated deficit",
                "concept": "RetainedEarningsAccumulatedDeficit",
                "unit": "usd",
                "value": -61450000
            },
            {
                "label": "Additional paid-in-capital",
                "concept": "AdditionalPaidInCapital",
                "unit": "usd",
                "value": 166805000
            },
            {
                "label": "Total current liabilities",
                "concept": "LiabilitiesCurrent",
                "unit": "usd",
                "value": 12530000
            },
            {
                "label": "Commitments and Contingencies",
                "concept": "CommitmentsAndContingencies",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Commitments and Contingencies",
                "concept": "CommitmentsAndContingencies",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Total liabilities",
                "concept": "Liabilities",
                "unit": "usd",
                "value": 12679000
            },
            {
                "label": "Accounts payable",
                "concept": "AccountsPayableCurrent",
                "unit": "usd",
                "value": 10685000
            },
            {
                "label": "Total stockholders' (deficit) equity",
                "concept": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
                "unit": "usd",
                "value": 105612000
            },
            {
                "label": "Common stock, $0.01 par value; 200,000,000 shares authorized, 39,900,886 shares issued and outstanding as of June 30, 2021; 12,767,909 shares issued and outstanding as of December 31, 2020",
                "concept": "CommonStockValue",
                "unit": "usd",
                "value": 399000
            },
            {
                "label": "Accrued liabilities",
                "concept": "AccruedLiabilitiesCurrent",
                "unit": "usd",
                "value": 1590000
            },
            {
                "label": "Other liabilities",
                "concept": "OtherLiabilitiesNoncurrent",
                "unit": "usd",
                "value": 149000
            },
            {
                "label": "Accumulated other comprehensive gain (loss)",
                "concept": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
                "unit": "usd",
                "value": -142000
            }
        ],
        "cf": [
            {
                "label": "Stock-based compensation expense",
                "concept": "ShareBasedCompensation",
                "unit": "usd",
                "value": 1335000
            },
            {
                "label": "Net realized gain/(loss) on sale of marketable securities",
                "concept": "MarketableSecuritiesRealizedGainLoss",
                "unit": "usd",
                "value": 2000
            },
            {
                "label": "Compensation expense related to vesting of common stock issued to Xontogeny",
                "concept": "labp:ShareBasedCompensationExpenseVestingOfCommonStock",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Net income/(loss)",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": 5721000
            },
            {
                "label": "Effect of exchange rates on cash",
                "concept": "EffectOfExchangeRateOnCashAndCashEquivalents",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Reclassification of series A and B convertible preferred stock to common stock",
                "concept": "labp:ReclassificationOfConvertiblePreferredStockToCommonStock",
                "unit": "usd",
                "value": 72925000
            },
            {
                "label": "Purchase of property and equipment",
                "concept": "PaymentsToAcquirePropertyPlantAndEquipment",
                "unit": "usd",
                "value": 213000
            },
            {
                "label": "Proceeds from sales and maturities of marketable securities",
                "concept": "ProceedsFromSaleAndMaturityOfMarketableSecurities",
                "unit": "usd",
                "value": 14289000
            },
            {
                "label": "Other liabilities",
                "concept": "IncreaseDecreaseInOtherCurrentLiabilities",
                "unit": "usd",
                "value": -349000
            },
            {
                "label": "Net cash provided by (used in) financing activities",
                "concept": "NetCashProvidedByUsedInFinancingActivities",
                "unit": "usd",
                "value": 90764000
            },
            {
                "label": "Deferred offering costs included in account payable and accrued liabilities",
                "concept": "labp:DeferredOfferingCostsIncludedInAccountPayableAndAccruedLiabilities",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Depreciation of property and equipment",
                "concept": "DepreciationAndAmortization",
                "unit": "usd",
                "value": 93000
            },
            {
                "label": "Reclassification of par to additional paid-in-capital",
                "concept": "labp:ReclassificationOfParToAdditionalPaidInCapital",
                "unit": "usd",
                "value": 2000
            },
            {
                "label": "Prepaid expenses and other assets",
                "concept": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
                "unit": "usd",
                "value": 1412000
            },
            {
                "label": "Purchase of available-for-sale marketable securities",
                "concept": "PaymentsToAcquireAvailableForSaleSecuritiesDebt",
                "unit": "usd",
                "value": 85409000
            },
            {
                "label": "Accrued interest on marketable securities",
                "concept": "labp:AccruedInterestOnMarketableSecurities",
                "unit": "usd",
                "value": 415000
            },
            {
                "label": "Net cash (used in) provided by investing activities",
                "concept": "NetCashProvidedByUsedInInvestingActivities",
                "unit": "usd",
                "value": -71333000
            },
            {
                "label": "Proceeds from exercise of stock options",
                "concept": "ProceedsFromStockOptionsExercised",
                "unit": "usd",
                "value": 258000
            },
            {
                "label": "Net cash (used in) operating activities",
                "concept": "NetCashProvidedByUsedInOperatingActivities",
                "unit": "usd",
                "value": -3160000
            },
            {
                "label": "Net proceeds from initial public offering",
                "concept": "ProceedsFromIssuanceInitialPublicOffering",
                "unit": "usd",
                "value": 90506000
            },
            {
                "label": "Net change in cash and cash equivalents",
                "concept": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
                "unit": "usd",
                "value": 16271000
            },
            {
                "label": "Gain/(loss) from foreign exchange",
                "concept": "ForeignCurrencyTransactionGainLossUnrealized",
                "unit": "usd",
                "value": 13000
            },
            {
                "label": "Incentive and tax receivables",
                "concept": "labp:IncreaseDecreaseInIncentiveAndIncomeTaxesReceivable",
                "unit": "usd",
                "value": -152000
            },
            {
                "label": "Unrealized gain on available-for-sale marketable securities",
                "concept": "AvailableForSaleEquitySecuritiesGrossUnrealizedLoss",
                "unit": "usd",
                "value": 152000
            },
            {
                "label": "Accounts payable",
                "concept": "IncreaseDecreaseInAccountsPayable",
                "unit": "usd",
                "value": 2067000
            },
            {
                "label": "Net (accretion of discount) amortixation of premium on marketable sercurities",
                "concept": "AccretionAmortizationOfDiscountsAndPremiumsInvestments",
                "unit": "usd",
                "value": -245000
            },
            {
                "label": "Purchase of fixed assets in accounts payable",
                "concept": "labp:PaymentsForPurchaseOfFixedAssetsInAccountsPayable",
                "unit": "usd",
                "value": "N/A"
            }
        ],
        "ic": [
            {
                "label": "Gain/(Loss) from operations",
                "concept": "OperatingIncomeLoss",
                "unit": "usd",
                "value": -6017000
            },
            {
                "label": "General and administrative",
                "concept": "GeneralAndAdministrativeExpense",
                "unit": "usd",
                "value": 5241000
            },
            {
                "label": "Net income/(loss)",
                "concept": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
                "unit": "usd",
                "value": -5721000
            },
            {
                "label": "Total operating expenses",
                "concept": "OperatingExpenses",
                "unit": "usd",
                "value": 24017000
            },
            {
                "label": "Other income (expense), net",
                "concept": "OtherNonoperatingIncomeExpense",
                "unit": "usd",
                "value": 296000
            },
            {
                "label": "Comprehensive income/(loss)",
                "concept": "ComprehensiveIncomeNetOfTax",
                "unit": "usd",
                "value": -5873000
            },
            {
                "label": "R&D Incentive Income",
                "concept": "labp:ResearchAndDevelopmentIncentiveIncome",
                "unit": "usd",
                "value": 41000
            },
            {
                "label": "Weighted-average shares used to compute net loss per share, basic",
                "concept": "WeightedAverageNumberOfSharesOutstandingBasic",
                "unit": "shares",
                "value": 29875877
            },
            {
                "label": "Weighted-average shares used to compute net loss per share, basic",
                "concept": "WeightedAverageNumberOfSharesOutstandingBasic",
                "unit": "shares",
                "value": 29875877
            },
            {
                "label": "Net income/(loss) per share, basic and diluted",
                "concept": "EarningsPerShareBasicAndDiluted",
                "unit": "usd/shares",
                "value": -0.19
            },
            {
                "label": "Net income/(loss)",
                "concept": "NetIncomeLoss",
                "unit": "usd",
                "value": -5721000
            },
            {
                "label": "Net income/(loss)",
                "concept": "NetIncomeLoss",
                "unit": "usd",
                "value": -5721000
            },
            {
                "label": "Unrealized gain/(loss) on available-for-sale securities",
                "concept": "DebtSecuritiesAvailableForSaleUnrealizedGainLoss",
                "unit": "usd",
                "value": -152000
            },
            {
                "label": "Other income, net",
                "concept": "OtherNonoperatingIncome",
                "unit": "usd",
                "value": 242000
            },
            {
                "label": "Gain/(loss) from foreign exchange",
                "concept": "ConversionGainsAndLossesOnForeignInvestments",
                "unit": "usd",
                "value": 13000
            },
            {
                "label": "Weighted-average shares used to compute net loss per share, diluted",
                "concept": "WeightedAverageNumberOfDilutedSharesOutstanding",
                "unit": "shares",
                "value": 29875877
            },
            {
                "label": "Weighted-average shares used to compute net loss per share, diluted",
                "concept": "WeightedAverageNumberOfDilutedSharesOutstanding",
                "unit": "shares",
                "value": 29875877
            },
            {
                "label": "Revenue - License Fee:",
                "concept": "RevenueFromContractWithCustomerIncludingAssessedTax",
                "unit": "usd",
                "value": 18000000
            },
            {
                "label": "Research and development",
                "concept": "ResearchAndDevelopmentExpense",
                "unit": "usd",
                "value": 18776000
            }
        ]
    }
}